JP2007526318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007526318A5 JP2007526318A5 JP2007501899A JP2007501899A JP2007526318A5 JP 2007526318 A5 JP2007526318 A5 JP 2007526318A5 JP 2007501899 A JP2007501899 A JP 2007501899A JP 2007501899 A JP2007501899 A JP 2007501899A JP 2007526318 A5 JP2007526318 A5 JP 2007526318A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- polypeptide
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 28
- 229920001184 polypeptide Polymers 0.000 claims 28
- 102000004196 processed proteins & peptides Human genes 0.000 claims 28
- 108090000765 processed proteins & peptides Proteins 0.000 claims 28
- 239000000203 mixture Substances 0.000 claims 25
- 239000012634 fragment Substances 0.000 claims 15
- 241001647372 Chlamydia pneumoniae Species 0.000 claims 12
- 230000028993 immune response Effects 0.000 claims 12
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 102000004169 proteins and genes Human genes 0.000 claims 10
- 230000002163 immunogen Effects 0.000 claims 9
- 150000001413 amino acids Chemical class 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 108010073429 Type V Secretion Systems Proteins 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 239000011230 binding agent Substances 0.000 claims 4
- 230000003308 immunostimulating effect Effects 0.000 claims 4
- 206010061041 Chlamydial infection Diseases 0.000 claims 3
- 208000035086 Chlamydophila Infections Diseases 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 229960001438 immunostimulant agent Drugs 0.000 claims 3
- 239000003022 immunostimulating agent Substances 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 210000000805 cytoplasm Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54983204P | 2004-03-02 | 2004-03-02 | |
| US64311005P | 2005-01-12 | 2005-01-12 | |
| US64455205P | 2005-01-19 | 2005-01-19 | |
| PCT/US2005/006588 WO2005084306A2 (en) | 2004-03-02 | 2005-03-02 | Immunogenic compositions for chlamydia pneunomiae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007526318A JP2007526318A (ja) | 2007-09-13 |
| JP2007526318A5 true JP2007526318A5 (enExample) | 2008-04-03 |
Family
ID=34923269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007501899A Withdrawn JP2007526318A (ja) | 2004-03-02 | 2005-03-02 | Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫原性組成物 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1729800A4 (enExample) |
| JP (1) | JP2007526318A (enExample) |
| BR (1) | BRPI0508365A (enExample) |
| CA (1) | CA2557353A1 (enExample) |
| RU (1) | RU2006134631A (enExample) |
| WO (1) | WO2005084306A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2595363T3 (es) | 2005-02-18 | 2016-12-29 | J. Craig Venter Institute, Inc. | Sepsis asociada a las proteínas y los ácidos nucleicos de meningitis / Escherichia coli |
| US8062644B2 (en) | 2005-02-18 | 2011-11-22 | Novartis Vaccines & Diagnostics Srl. | Immunogens from uropathogenic Escherichia coli |
| WO2008020330A2 (en) | 2006-08-16 | 2008-02-21 | Novartis Ag | Immunogens from uropathogenic escherichia coli |
| CN102105786B (zh) * | 2008-07-25 | 2014-10-29 | 赛乐思迪斯有限公司 | 诊断方法 |
| US20110236489A1 (en) | 2008-09-18 | 2011-09-29 | Novartis Ag | Vaccine adjuvant combinations |
| ITMI20090946A1 (it) | 2009-05-28 | 2010-11-29 | Novartis Ag | Espressione di proteine ricombinanti |
| CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
| ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
| CN102933267B (zh) | 2010-05-28 | 2015-05-27 | 泰特里斯在线公司 | 交互式混合异步计算机游戏基础结构 |
| CN105999275A (zh) | 2010-09-01 | 2016-10-12 | 诺华有限公司 | 免疫增强剂吸附不溶性金属离子 |
| US9618508B2 (en) | 2010-12-14 | 2017-04-11 | Glaxosmithkline Biologicals Sa | Flow cytometry analysis of materials adsorbed to metal salts |
| US20140112950A1 (en) | 2011-03-02 | 2014-04-24 | Manmohan Singh | Combination vaccines with lower doses of antigen and/or adjuvant |
| HRP20161354T1 (hr) | 2012-03-07 | 2016-12-02 | Glaxosmithkline Biologicals Sa | Argininske soli agonista tlr7 |
| JP2015510872A (ja) | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 |
| US9375471B2 (en) | 2012-03-08 | 2016-06-28 | Glaxosmithkline Biologicals Sa | Adjuvanted formulations of booster vaccines |
| JP6990522B2 (ja) * | 2017-04-11 | 2022-02-03 | シスメックス株式会社 | 免疫細胞の免疫刺激応答性を測定する方法、免疫細胞における免疫シナプスの形成能を判定する方法及び細胞分析装置 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6822071B1 (en) * | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
| ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
-
2005
- 2005-03-02 RU RU2006134631/13A patent/RU2006134631A/ru not_active Application Discontinuation
- 2005-03-02 CA CA002557353A patent/CA2557353A1/en not_active Abandoned
- 2005-03-02 WO PCT/US2005/006588 patent/WO2005084306A2/en not_active Ceased
- 2005-03-02 JP JP2007501899A patent/JP2007526318A/ja not_active Withdrawn
- 2005-03-02 EP EP05724183A patent/EP1729800A4/en not_active Withdrawn
- 2005-03-02 BR BRPI0508365-6A patent/BRPI0508365A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007526318A5 (enExample) | ||
| CA2759583C (en) | A tuberculosis tb vaccine to prevent reactivation | |
| JP2008534594A5 (enExample) | ||
| JP2004512824A5 (enExample) | ||
| EP2289544A3 (en) | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto | |
| JP2008543890A (ja) | 改良された結核ワクチン | |
| RU2006134631A (ru) | Иммуногенные композиции против chlamidia pneumoniae | |
| JP5437813B2 (ja) | Ｓ．アガラクティエの防御タンパク質、その組み合わせ、およびそれを使用する方法 | |
| BR9810288A (pt) | Teste diagnóstico especìfico para espécie para identificar infecção de um mamìfero, como um humano, com chlamydia pneumoniae, fragmento de ácido nucleico derivado de chlamydia pneumoniae, proteìna derivada de chlamydia pneumoniae, anticorpo monoespecìfico policlonal, kit diagnóstico para o diagnóstico de infecção de um mamìfero, como um humano, com chlamydia pneumoniae, composição para imunizar um mamìfero comoum humano, contra chlamydia pneumoniae, uso de uma proteìna, e, uso de um fragmento de ácido nucleico. | |
| JP2010535504A5 (enExample) | ||
| PT1219301E (pt) | Vacinas contendo polipéptidos híbridos, consistindo em, pelo menos, duas proteínas alergénicas diferentes | |
| KR101881947B1 (ko) | 기생충 질병에 대한 백신 또는 진단용으로 사용되는 ｌ3 및/또는 ｌ5 공급원의 용도 | |
| WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
| Lin et al. | Molecular characterization of three major outer membrane proteins, TSA56, TSA47 and TSA22, in Orientia tsutsugamushi | |
| Hoff et al. | Molecular cloning and immunological characterisation of potential allergens from the mould Fusarium culmorum | |
| CA2338886A1 (en) | Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response | |
| CN101466831A (zh) | 用于诊断和治疗利什曼病的化合物和方法 | |
| JP2009525741A5 (ja) | HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド | |
| CN101977927A (zh) | 针对肺炎链球菌保护的肽以及与其有关的组合物、方法和用途 | |
| JP4730764B2 (ja) | スギ花粉由来の新規アレルゲン | |
| CN117396493A (zh) | 氨基酸、核苷酸和表达它们的载体及其在预防沙贝病毒感染中的用途 | |
| CN101248084A (zh) | 包含潜伏感染阶段期间所表达的抗原的结核疫苗 | |
| KR101954663B1 (ko) | 뎅기열 바이러스 ns1에 특이적으로 결합하는 어피바디 이종이량체 및 그의 용도 | |
| KR101954685B1 (ko) | 뎅기열 바이러스 ns1에 특이적으로 결합하는 어피바디 동종이량체 및 그의 용도 | |
| JP2002541067A5 (enExample) |